Aetna (NYSE:AET) issued its earnings results on Tuesday, October 30th. The company reported $2.96 EPS for the quarter, beating the consensus estimate of $2.83 by $0.13, MarketWatch Earnings reports. The business had revenue of $15.48 billion for the quarter, compared to the consensus estimate of $15.40 billion. Aetna had a return on equity of 20.78% and a net margin of 5.99%. The company’s revenue was up 3.3% compared to the same quarter last year. During the same period last year, the business posted $2.45 EPS.
NYSE:AET traded up $0.30 on Thursday, reaching $204.30. 3,893,474 shares of the company’s stock traded hands, compared to its average volume of 2,729,125. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.42. The stock has a market cap of $66.79 billion, a PE ratio of 20.72, a P/E/G ratio of 1.72 and a beta of 0.71. Aetna has a 12 month low of $166.88 and a 12 month high of $210.90.
The firm also recently declared a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 0.98%. Aetna’s dividend payout ratio is presently 20.28%.
AET has been the topic of a number of research reports. Piper Jaffray Companies downgraded Aetna from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $212.00 to $206.00 in a research note on Tuesday, October 30th. Zacks Investment Research downgraded Aetna from a “buy” rating to a “hold” rating in a research note on Monday. Credit Suisse Group dropped their price target on Aetna from $207.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 31st. Cantor Fitzgerald downgraded Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 price target on the stock. in a research note on Wednesday, August 22nd. Finally, Citigroup raised their target price on Aetna from $202.00 to $206.00 and gave the stock a “neutral” rating in a report on Wednesday, October 31st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $204.55.
TRADEMARK VIOLATION WARNING: “Aetna (NYSE:AET) Releases Quarterly Earnings Results, Beats Expectations By $0.13 EPS” was reported by Enterprise Leader and is owned by of Enterprise Leader. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://theenterpriseleader.com/2018/11/22/aetna-aet-announces-earnings-results.html.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
See Also: Balance Sheet
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.